Data:
{
"symbol": "TAK",
"price": 18.635,
"marketCap": 59299296189,
"beta": 0.088,
"lastDividend": 0.63041,
"range": "12.99-18.9",
"change": 0.205,
"changePercentage": 1.11232,
"volume": 739314,
"averageVolume": 3181645,
"companyName": "Takeda Pharmaceutical Company Limited",
"currency": "USD",
"cik": "0001395064",
"isin": "US8740602052",
"cusip": "874060205",
"exchangeFullName": "New York Stock Exchange",
"exchange": "NYSE",
"industry": "Drug Manufacturers - Specialty & Generic",
"website": "https://www.takeda.com",
"description": "Takeda Pharmaceutical Company Limited is a prominent global biopharmaceutical entity dedicated to the discovery, development, manufacturing, commercialization, and out-licensing of pharmaceutical products. The company's operations extend across a vast international footprint, encompassing Japan, the United States, Europe, Canada, Latin America, Russia, and numerous other Asian and worldwide markets. Its extensive portfolio of medicines targets critical therapeutic areas, including digestive disorders (gastroenterology), rare diseases, plasma-derived treatments, cancer care (oncology), and neurological conditions. Takeda markets these products under various well-recognized brand names, such as Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig. To further its innovative endeavors, Takeda engages in a wide array of strategic partnerships. These include out-licensing arrangements, notably with Neurocrine Biosciences, Inc.; numerous collaboration and in-licensing agreements with institutions like the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., Ovid Therapeutics Inc., and Evox Therapeutics Ltd.; and a licensing deal with ProThera Biologics Inc. The company also fosters research collaborations and licensing agreements with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio. Furthermore, it maintains strategic alliances with Egle Therapeutics SAS, Evotec SE, Neurocrine Biosciences, Inc., Carmine Therapeutics, KSQ Therapeutics, and Anima Biotech. Founded in 1781, Takeda Pharmaceutical Company Limited is headquartered in Tokyo, Japan.",
"ceo": "Julie So-Young Kim",
"sector": "Healthcare",
"country": "JP",
"fullTimeEmployees": "47029",
"phone": "81 3 3278 2111",
"address": "1-1, Nihonbashi-Honcho 2-chome",
"city": "Tokyo",
"state": "OS",
"zip": "103-8668",
"image": "https://images.financialmodelingprep.com/symbol/TAK.png",
"ipoDate": "2010-01-05",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": true,
"isFund": false
}
Data:
{
"symbol": "TAK",
"name": "Takeda Pharmaceutical Company Limited",
"price": 18.635,
"changePercentage": 1.11232,
"change": 0.205,
"volume": 739314,
"dayLow": 18.53,
"dayHigh": 18.835,
"yearHigh": 18.9,
"yearLow": 12.99,
"marketCap": 59299296189,
"priceAvg50": 17.1778,
"priceAvg200": 16.7196,
"exchange": "NYSE",
"open": 18.745,
"previousClose": 18.43,
"timestamp": 1788444528,
"chart_vwap_daily": [
{
"t": "2026-07-24",
"v": 17.2577,
"c": 17.24
},
{
"t": "2026-07-27",
"v": 17.492,
"c": 17.44
},
{
"t": "2026-07-28",
"v": 17.5921,
"c": 17.52
},
{
"t": "2026-07-29",
"v": 17.7426,
"c": 17.75
},
{
"t": "2026-07-30",
"v": 17.171,
"c": 17.25
},
{
"t": "2026-07-31",
"v": 17.0978,
"c": 17.09
},
{
"t": "2026-08-03",
"v": 16.8982,
"c": 16.83
},
{
"t": "2026-08-04",
"v": 16.5531,
"c": 16.56
},
{
"t": "2026-08-05",
"v": 16.6566,
"c": 16.72
},
{
"t": "2026-08-06",
"v": 17.0052,
"c": 17.02
},
{
"t": "2026-08-07",
"v": 17.4624,
"c": 17.45
},
{
"t": "2026-08-10",
"v": 17.5194,
"c": 17.55
},
{
"t": "2026-08-11",
"v": 17.4971,
"c": 17.48
},
{
"t": "2026-08-12",
"v": 17.412,
"c": 17.41
},
{
"t": "2026-08-13",
"v": 17.4098,
"c": 17.39
},
{
"t": "2026-08-14",
"v": 17.5984,
"c": 17.63
},
{
"t": "2026-08-17",
"v": 17.3783,
"c": 17.38
},
{
"t": "2026-08-18",
"v": 18.0655,
"c": 18.05
},
{
"t": "2026-08-19",
"v": 18.3517,
"c": 18.34
},
{
"t": "2026-08-20",
"v": 18.1824,
"c": 18.13
},
{
"t": "2026-08-21",
"v": 18.1686,
"c": 18.18
},
{
"t": "2026-08-24",
"v": 18.2039,
"c": 18.24
},
{
"t": "2026-08-25",
"v": 18.3066,
"c": 18.35
},
{
"t": "2026-08-26",
"v": 18.2484,
"c": 18.23
},
{
"t": "2026-08-27",
"v": 18.065,
"c": 18.03
},
{
"t": "2026-08-28",
"v": 18.0143,
"c": 18.03
},
{
"t": "2026-08-31",
"v": 17.9979,
"c": 17.98
},
{
"t": "2026-09-01",
"v": 18.2523,
"c": 18.23
},
{
"t": "2026-09-02",
"v": 18.4099,
"c": 18.43
},
{
"t": "2026-09-03",
"v": 18.71,
"c": 18.66
}
],
"vwap_summary": {
"days": 30,
"days_above": 13,
"days_below": 17,
"pct_days_above": 43,
"position": "below",
"gap_pct": -0.27,
"streak_days": 1
}
}
Data:
{
"volume": 739314,
"avgVolume": 3181645,
"short_ratio": [
{
"symbol": "TAK",
"file_date": "2026-09-02",
"date": "20260902",
"short_volume": 177564,
"short_exempt_volume": 103,
"total_volume": 727912,
"short_volume_ratio": 0.2439,
"signal": "Bullish"
}
],
"volume_profile": {
"poc": 17.41,
"vah": 18.2,
"val": 17.35,
"profile": [
{
"price": 17.36,
"volume": 644766
},
{
"price": 17.39,
"volume": 2080181
},
{
"price": 17.41,
"volume": 2495077
},
{
"price": 17.43,
"volume": 1584720
},
{
"price": 17.46,
"volume": 1397595
},
{
"price": 17.48,
"volume": 1920030
},
{
"price": 17.51,
"volume": 1783079
},
{
"price": 17.53,
"volume": 2163762
},
{
"price": 17.56,
"volume": 1252328
},
{
"price": 17.58,
"volume": 545495
},
{
"price": 17.6,
"volume": 945066
},
{
"price": 17.63,
"volume": 934693
},
{
"price": 17.65,
"volume": 108037
},
{
"price": 17.68,
"volume": 0
},
{
"price": 17.7,
"volume": 0
},
{
"price": 17.73,
"volume": 0
},
{
"price": 17.75,
"volume": 0
},
{
"price": 17.77,
"volume": 0
},
{
"price": 17.8,
"volume": 0
},
{
"price": 17.82,
"volume": 0
},
{
"price": 17.85,
"volume": 0
},
{
"price": 17.87,
"volume": 0
},
{
"price": 17.89,
"volume": 0
},
{
"price": 17.92,
"volume": 0
},
{
"price": 17.94,
"volume": 0
},
{
"price": 17.97,
"volume": 755769
},
{
"price": 17.99,
"volume": 1528007
},
{
"price": 18.02,
"volume": 1464177
},
{
"price": 18.04,
"volume": 865545
},
{
"price": 18.06,
"volume": 1493993
},
{
"price": 18.09,
"volume": 1682529
},
{
"price": 18.11,
"volume": 1006548
},
{
"price": 18.14,
"volume": 789852
},
{
"price": 18.16,
"volume": 1335486
},
{
"price": 18.19,
"volume": 955685
},
{
"price": 18.21,
"volume": 1012270
},
{
"price": 18.23,
"volume": 2277239
},
{
"price": 18.26,
"volume": 1083489
},
{
"price": 18.28,
"volume": 1237619
},
{
"price": 18.31,
"volume": 712711
},
{
"price": 18.33,
"volume": 878393
},
{
"price": 18.36,
"volume": 817918
},
{
"price": 18.38,
"volume": 1083105
},
{
"price": 18.4,
"volume": 653110
},
{
"price": 18.43,
"volume": 722711
},
{
"price": 18.45,
"volume": 313367
},
{
"price": 18.48,
"volume": 192767
},
{
"price": 18.5,
"volume": 0
},
{
"price": 18.53,
"volume": 0
},
{
"price": 18.55,
"volume": 0
},
{
"price": 18.57,
"volume": 80104
},
{
"price": 18.6,
"volume": 61789
},
{
"price": 18.62,
"volume": 64089
},
{
"price": 18.65,
"volume": 17029
},
{
"price": 18.67,
"volume": 109385
},
{
"price": 18.7,
"volume": 0
},
{
"price": 18.72,
"volume": 0
},
{
"price": 18.74,
"volume": 67701
},
{
"price": 18.77,
"volume": 0
},
{
"price": 18.79,
"volume": 287219
}
],
"sessions": 20
}
}
Data:
{
"symbol": "TAK",
"marketCap": 9400060152476,
"enterpriseValueTTM": 13879046152476,
"evToSalesTTM": 3.004815212267763,
"evToOperatingCashFlowTTM": 15.509150974837244,
"evToFreeCashFlowTTM": 19.819762221445373,
"evToEBITDATTM": 11.040280824606564,
"netDebtToEBITDATTM": 3.562871879394938,
"currentRatioTTM": 1.139524486290159,
"incomeQualityTTM": 4.947391116860715,
"grahamNumberTTM": 3547.7140612434887,
"grahamNetNetTTM": -1963.45,
"taxBurdenTTM": 0.6637211369304055,
"interestBurdenTTM": 0.4642119153811531,
"workingCapitalTTM": 385722000000,
"investedCapitalTTM": 11806059000000,
"returnOnAssetsTTM": 0.011537564535530287,
"operatingReturnOnAssetsTTM": 0.031232228012098063,
"returnOnTangibleAssetsTTM": 0.028302262069838224,
"returnOnEquityTTM": 0.024011331760555407,
"returnOnInvestedCapitalTTM": 0.024072804704572123,
"returnOnCapitalEmployedTTM": 0.03767171078317514,
"earningsYieldTTM": 0.019575594897905058,
"freeCashFlowYieldTTM": 0.07449558711765786,
"capexToOperatingCashFlowTTM": 0.21749056312814702,
"capexToDepreciationTTM": 0.2770417902077198,
"capexToRevenueTTM": 0.042137635623796396,
"salesGeneralAndAdministrativeToRevenueTTM": 0.2413636476806883,
"researchAndDevelopementToRevenueTTM": 0.15142624869152738,
"stockBasedCompensationToRevenueTTM": 0.011847536282714522,
"intangiblesToTotalAssetsTTM": 0.5923447918381799,
"averageReceivablesTTM": 916244000000,
"averagePayablesTTM": 469064500000,
"averageInventoryTTM": 1421939500000,
"daysOfSalesOutstandingTTM": 75.55661640616289,
"daysOfPayablesOutstandingTTM": 93.27026708593901,
"daysOfInventoryOutstandingTTM": 302.1286202561618,
"operatingCycleTTM": 377.6852366623247,
"cashConversionCycleTTM": 284.4149695763857,
"freeCashFlowToEquityTTM": 706287000000,
"freeCashFlowToFirmTTM": 904977592888.8596,
"tangibleAssetValueTTM": -1719181000000,
"netCurrentAssetValueTTM": -4954126000000,
"grossProfitMarginTTM": 0.6214655542890298,
"ebitMarginTTM": 0.1269851166989793,
"ebitdaMarginTTM": 0.2721683678163906,
"operatingProfitMarginTTM": 0.10520109072762444,
"pretaxProfitMarginTTM": 0.05894800424773243,
"continuousOperationsProfitMarginTTM": 0.039187171934655936,
"netProfitMarginTTM": 0.03912503639908334,
"bottomLineProfitMarginTTM": 0.03912503639908334,
"receivablesTurnoverTTM": 4.830814525069551,
"payablesTurnoverTTM": 3.913358580432603,
"inventoryTurnoverTTM": 1.208094750144929,
"fixedAssetTurnoverTTM": 2.15608370521127,
"assetTurnoverTTM": 0.2948895540401491,
"quickRatioTTM": 0.6160177417855439,
"solvencyRatioTTM": 0.10504275766420566,
"cashRatioTTM": 0.16674775288682014,
"priceToEarningsRatioTTM": 51.72474172649274,
"priceToEarningsGrowthRatioTTM": 1.6790351106161123,
"forwardPriceToEarningsGrowthRatioTTM": 0.8714658368767619,
"priceToEarningsDilutedRatioTTM": 52.66535924407202,
"priceToEarningsDilutedGrowthRatioTTM": 1.6256232745902464,
"priceToBookRatioTTM": 1.2214656038122824,
"priceToSalesRatioTTM": 2.0351141881139267,
"priceToFreeCashFlowRatioTTM": 13.423613917165408,
"priceToOperatingCashFlowRatioTTM": 10.3159692745733,
"debtToAssetsRatioTTM": 0.3153854645048279,
"debtToEquityRatioTTM": 0.6536176050263784,
"debtToCapitalRatioTTM": 0.3952652675199064,
"longTermDebtToCapitalRatioTTM": 0.36901322729346625,
"financialLeverageRatioTTM": 2.0724404850191593,
"workingCapitalTurnoverRatioTTM": 8.825751532203746,
"operatingCashFlowRatioTTM": 0.3237036664596406,
"operatingCashFlowSalesRatioTTM": 0.19374466191881895,
"freeCashFlowOperatingCashFlowRatioTTM": 0.7825094368718529,
"debtServiceCoverageRatioTTM": 1.3975227425563004,
"interestCoverageRatioTTM": 1.546230975087428,
"shortTermOperatingCashFlowCoverageRatioTTM": 1.7210492913052675,
"operatingCashFlowCoverageRatioTTM": 0.18115380504489098,
"capitalExpenditureCoverageRatioTTM": 4.597900642754751,
"dividendPaidAndCapexCoverageRatioTTM": 1.75,
"dividendPayoutRatioTTM": 1.752678235463379,
"dividendYieldTTM": 0.0338524,
"revenuePerShareTTM": 1477.99,
"netIncomePerShareTTM": 57.83,
"interestDebtPerShareTTM": 1681.27,
"cashPerShareTTM": 168.82,
"bookValuePerShareTTM": 2418.72,
"tangibleBookValuePerShareTTM": -550.11,
"shareholdersEquityPerShareTTM": 2418.41,
"operatingCashFlowPerShareTTM": 286.35,
"capexPerShareTTM": 62.28,
"freeCashFlowPerShareTTM": 224.07,
"netIncomePerEBTTTM": 0.6637211369304055,
"ebtPerEbitTTM": 0.5603364360580099,
"priceToFairValueTTM": 1.2214656038122824,
"debtToMarketCapTTM": 0.5255251476979963,
"effectiveTaxRateTTM": 0.33522478946073303,
"enterpriseValueMultipleTTM": 11.040280824606564,
"dividendPerShareTTM": 100,
"revenue_history": [
{
"date": "2025",
"revenue": 4581551000000
},
{
"date": "2026",
"revenue": 4777450268000
}
],
"dcf": {
"symbol": "TAK",
"date": "2026-09-03",
"dcf": 31.822725110821747,
"Stock Price": 18.43
},
"statements": {
"income": [
{
"date": "2026-03-31",
"symbol": "TAK",
"reportedCurrency": "JPY",
"cik": "0001395064",
"filingDate": "2026-06-17",
"acceptedDate": "2026-06-17 06:06:13",
"fiscalYear": "2025",
"period": "FY",
"revenue": 4777450268000,
"costOfRevenue": 2338118761000,
"grossProfit": 2439331507000,
"researchAndDevelopmentExpenses": 716687520000,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 1149601671000,
"otherExpenses": 0,
"operatingExpenses": 1866289192000,
"costAndExpenses": 4204407953000,
"netInterestIncome": -155223767000,
"interestIncome": 223912630000,
"interestExpense": 379136397000,
"depreciationAndAmortization": 764616616000,
"ebitda": 1419633451000,
"ebit": 655016835000,
"nonOperatingIncomeExcludingInterest": -81974520000,
"operatingIncome": 573042315000,
"totalOtherIncomeExpensesNet": -297161877000,
"incomeBeforeTax": 275880438000,
"incomeTaxExpense": 72273764000,
"netIncomeFromContinuingOperations": 203606675000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 203326753000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 203326753000,
"eps": 63.91,
"epsDiluted": 63.91,
"weightedAverageShsOut": 3150124000,
"weightedAverageShsOutDil": 3205566000
}
],
"balance_sheet": [
{
"date": "2026-03-31",
"symbol": "TAK",
"reportedCurrency": "JPY",
"cik": "0001395064",
"filingDate": "2026-06-17",
"acceptedDate": "2026-06-17 06:06:13",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 597634849000,
"shortTermInvestments": 0,
"cashAndShortTermInvestments": 597634849000,
"netReceivables": 880148868000,
"accountsReceivables": 847973923000,
"otherReceivables": 32174946000,
"inventory": 1402677375000,
"prepaids": 0,
"otherCurrentAssets": 223445937000,
"totalCurrentAssets": 3103907030000,
"propertyPlantEquipmentNet": 2129836567000,
"goodwill": 5834204650000,
"intangibleAssets": 3434178285000,
"goodwillAndIntangibleAssets": 9268382936000,
"longTermInvestments": 450683248000,
"taxAssets": 489982961000,
"otherNonCurrentAssets": 77343001000,
"totalNonCurrentAssets": 12416228712000,
"otherAssets": 0,
"totalAssets": 15520135742000,
"totalPayables": 591780567000,
"accountPayables": 493476046000,
"otherPayables": 98304522000,
"accruedExpenses": 0,
"shortTermDebt": 514378311000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 1333908401000,
"totalCurrentLiabilities": 2440067279000,
"longTermDebt": 4388633039000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 26920253000,
"otherNonCurrentLiabilities": 855995564000,
"totalNonCurrentLiabilities": 5271548856000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 7711616135000,
"treasuryStock": -49341076000,
"preferredStock": 0,
"commonStock": 1702629701000,
"retainedEarnings": 1061114356000,
"additionalPaidInCapital": 1784056336000,
"accumulatedOtherComprehensiveIncomeLoss": 3308848055000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 7807307372000,
"totalEquity": 7808520611000,
"minorityInterest": 1213239000,
"totalLiabilitiesAndTotalEquity": 15520135742000,
"totalInvestments": 450683248000,
"totalDebt": 4903011350000,
"netDebt": 4305376501000
}
],
"cash_flow": [
{
"date": "2026-03-31",
"symbol": "TAK",
"reportedCurrency": "JPY",
"cik": "0001395064",
"filingDate": "2026-06-17",
"acceptedDate": "2026-06-17 06:06:13",
"fiscalYear": "2025",
"period": "FY",
"netIncome": -152125000000,
"depreciationAndAmortization": 721127000000,
"deferredIncomeTax": 9770000000,
"stockBasedCompensation": 72775000000,
"changeInWorkingCapital": 199905000000,
"accountsReceivables": -70166000000,
"inventory": -61293000000,
"accountsPayables": 0,
"otherWorkingCapital": 331364000000,
"otherNonCashItems": 189979000000,
"netCashProvidedByOperatingActivities": 1041431000000,
"investmentsInPropertyPlantAndEquipment": -176003000000,
"acquisitionsNet": 33582000000,
"purchasesOfInvestments": -17431000000,
"salesMaturitiesOfInvestments": 7031000000,
"otherInvestingActivities": -216320000000,
"netCashProvidedByInvestingActivities": -369141000000,
"netDebtIssuance": 1076000000,
"longTermNetDebtIssuance": 342856000000,
"shortTermNetDebtIssuance": -341780000000,
"netStockIssuance": -51603000000,
"netCommonStockIssuance": -51603000000,
"commonStockIssuance": 0,
"commonStockRepurchased": -51603000000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": -311901000000,
"commonDividendsPaid": -311901000000,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -134392000000,
"netCashProvidedByFinancingActivities": -496820000000,
"effectOfForexChangesOnCash": 34472000000,
"netChangeInCash": 209941000000,
"cashAtEndOfPeriod": 595054000000,
"cashAtBeginningOfPeriod": 385113000000,
"operatingCashFlow": 1041431000000,
"capitalExpenditure": -414659000000,
"freeCashFlow": 626772000000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 18.6391,
"rsi": 67.77813289188391,
"sma20": 17.957454999999968,
"sma50": 17.236182000000003,
"sma200": 16.741345500000012,
"adx": 27.70361210819387,
"atr": 0.29,
"atr_pct": 1.56,
"atr_expansion_pct": -19.0,
"di_plus": 48.3,
"di_minus": 15.0,
"high_52w": 18.8,
"low_52w": 13.23,
"structure": {
"ema8": 18.269487506722754,
"ema21": 17.934327749833376,
"ema50": 17.422730620206114,
"ema200": 16.62657874403958,
"ema10": 18.215547698336756,
"ema20": 17.958474566452338,
"ema10_slope_pct": 1.09,
"ema20_slope_pct": 1.23,
"trend_dir": "up",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": false,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": true
},
"dist_21ema_pct": 3.9,
"_no_bars": false,
"macd": {
"macd": 0.345,
"signal": 0.333,
"histogram": 0.013
},
"bollinger": {
"mid": 17.96,
"upper": 18.74,
"lower": 17.18,
"width_pct": 8.67
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": 2.8,
"ret_3d": 3.67,
"ret_5d": 3.38,
"roc10_accel": -0.87,
"checks": {
"roc_over_5": false,
"rsi_in_band": true,
"macd_expanding": true,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.32,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": false
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": -1.55,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": false,
"avg_vol_over_2m": true,
"mcap_over_1b": true,
"no_earnings_7d": true,
"not_lev_etf_spac": true,
"bidask_spread": null,
"dollar_vol_over_10m": true
},
"avg_dollar_vol": 59289954.575,
"avg_vol": 3181645
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": true,
"oi_calls_above_price": true
},
"vals": {
"call_vol_mult": 0.1,
"iv_rank": 42.0
}
}
}
}
Data:
{
"prior_day": {
"high": 18.84,
"low": 18.52,
"close": 18.64,
"date": "2026-09-03"
},
"woodie_pivots": {
"PP": 18.66,
"R1": 18.8,
"S1": 18.48,
"R2": 18.97,
"S2": 18.34
},
"swing": {
"high_20d": 18.84,
"low_20d": 17.28,
"high_60d": 18.84,
"low_60d": 15.34
},
"orb": {
"high": 18.84,
"low": 18.64,
"date": "2026-09-03"
},
"vwap": 18.71,
"volume_profile": {
"poc": 17.41,
"vah": 18.2,
"val": 17.35,
"sessions": 20
},
"premarket": {
"date": "2026-09-03",
"high": 18.79,
"low": 18.45,
"last": 18.75,
"volume": 46374,
"gap_pct": 1.74,
"path": "04:00 18.50 -> 07:20 18.64 -> 08:15 18.65 -> 08:50 18.77 -> 09:20 18.76 -> 09:25 18.75",
"bars": 18,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-07-31",
"o": 17.06,
"h": 17.19,
"l": 16.932,
"c": 17.09,
"v": 4109517.343786
},
{
"d": "2026-08-03",
"o": 17.19,
"h": 17.22,
"l": 16.83,
"c": 16.83,
"v": 3154338.841522
},
{
"d": "2026-08-04",
"o": 16.35,
"h": 16.681,
"l": 16.3,
"c": 16.56,
"v": 5910580.891164
},
{
"d": "2026-08-05",
"o": 16.66,
"h": 16.78,
"l": 16.57,
"c": 16.72,
"v": 4865208.17779
},
{
"d": "2026-08-06",
"o": 17.07,
"h": 17.275,
"l": 16.91,
"c": 17.02,
"v": 4272051.085011
},
{
"d": "2026-08-07",
"o": 17.48,
"h": 17.56,
"l": 17.405,
"c": 17.45,
"v": 4253812.79263
},
{
"d": "2026-08-10",
"o": 17.48,
"h": 17.61,
"l": 17.42,
"c": 17.55,
"v": 4172282.342287
},
{
"d": "2026-08-11",
"o": 17.38,
"h": 17.635,
"l": 17.36,
"c": 17.48,
"v": 2339231.13869
},
{
"d": "2026-08-12",
"o": 17.36,
"h": 17.47,
"l": 17.35,
"c": 17.41,
"v": 2004374.894967
},
{
"d": "2026-08-13",
"o": 17.47,
"h": 17.47,
"l": 17.36,
"c": 17.39,
"v": 1953294.785626
},
{
"d": "2026-08-14",
"o": 17.5,
"h": 17.66,
"l": 17.48,
"c": 17.63,
"v": 3137294.284437
},
{
"d": "2026-08-17",
"o": 17.4,
"h": 17.4398,
"l": 17.28,
"c": 17.38,
"v": 2465382.999337
},
{
"d": "2026-08-18",
"o": 17.86,
"h": 18.16,
"l": 17.8341,
"c": 18.05,
"v": 3809695.245852
},
{
"d": "2026-08-19",
"o": 18.22,
"h": 18.495,
"l": 18.22,
"c": 18.34,
"v": 3309734.270061
},
{
"d": "2026-08-20",
"o": 18.25,
"h": 18.34,
"l": 18.105,
"c": 18.13,
"v": 2225255.687302
},
{
"d": "2026-08-21",
"o": 18.09,
"h": 18.245,
"l": 18.08,
"c": 18.18,
"v": 1479068.307549
},
{
"d": "2026-08-24",
"o": 18.24,
"h": 18.26,
"l": 18.11,
"c": 18.24,
"v": 2232970.279075
},
{
"d": "2026-08-25",
"o": 18.21,
"h": 18.355,
"l": 18.21,
"c": 18.35,
"v": 1247328.781125
},
{
"d": "2026-08-26",
"o": 18.32,
"h": 18.38,
"l": 18.2191,
"c": 18.23,
"v": 2331743.16982
},
{
"d": "2026-08-27",
"o": 18.21,
"h": 18.22,
"l": 17.971,
"c": 18.03,
"v": 1727773.249051
},
{
"d": "2026-08-28",
"o": 18,
"h": 18.11,
"l": 17.96,
"c": 18.03,
"v": 1809972.687457
},
{
"d": "2026-08-31",
"o": 17.99,
"h": 18.06,
"l": 17.955,
"c": 17.98,
"v": 1779519.162314
},
{
"d": "2026-09-01",
"o": 18.18,
"h": 18.405,
"l": 18.18,
"c": 18.23,
"v": 1899444.926389
},
{
"d": "2026-09-02",
"o": 18.3,
"h": 18.495,
"l": 18.275,
"c": 18.43,
"v": 1721820.164664
},
{
"d": "2026-09-03",
"o": 18.75,
"h": 18.835,
"l": 18.52,
"c": 18.6391,
"v": 741553.64316
}
]
}
Data:
{
"estimates": [
{
"symbol": "TAK",
"date": "2031-03-31",
"revenueLow": 5125499122191,
"revenueHigh": 5460099643026,
"revenueAvg": 5280555558595,
"ebitdaLow": 1401110958040,
"ebitdaHigh": 1456066563546,
"ebitdaAvg": 1426577796861,
"ebitLow": 814183885869,
"ebitHigh": 869139491375,
"ebitAvg": 839650724690,
"netIncomeLow": 508078717091,
"netIncomeHigh": 551592223992,
"netIncomeAvg": 528243201798,
"sgaExpenseLow": 1255641938915,
"sgaExpenseHigh": 1337612189368,
"sgaExpenseAvg": 1293627578910,
"epsAvg": 164.78937,
"epsHigh": 172.07327,
"epsLow": 158.49891,
"numAnalystsRevenue": 3,
"numAnalystsEps": 1
},
{
"symbol": "TAK",
"date": "2030-03-31",
"revenueLow": 5093615431991,
"revenueHigh": 5426134536151,
"revenueAvg": 5247707324014,
"ebitdaLow": 1326902921434,
"ebitdaHigh": 1374058794912,
"ebitdaAvg": 1348755312498,
"ebitLow": 723111292023,
"ebitHigh": 770267165501,
"ebitAvg": 744963683087,
"netIncomeLow": 435968003283,
"netIncomeHigh": 473305730838,
"netIncomeAvg": 453270590719,
"sgaExpenseLow": 1247831090132,
"sgaExpenseHigh": 1329291436280,
"sgaExpenseAvg": 1285580436578,
"epsAvg": 141.40111,
"epsHigh": 147.65122,
"epsLow": 136.00344,
"numAnalystsRevenue": 4,
"numAnalystsEps": 1
},
{
"symbol": "TAK",
"date": "2029-03-31",
"revenueLow": 4839680793787,
"revenueHigh": 5155622651482,
"revenueAvg": 4986090663212,
"ebitdaLow": 1275477397975,
"ebitdaHigh": 1316354393651,
"ebitdaAvg": 1294420101716,
"ebitLow": 649797219780,
"ebitHigh": 690674215456,
"ebitAvg": 668739923521,
"netIncomeLow": 377918376515,
"netIncomeHigh": 410284527648,
"netIncomeAvg": 392917091611,
"sgaExpenseLow": 1185622322972,
"sgaExpenseHigh": 1263021584453,
"sgaExpenseAvg": 1221489731772,
"epsAvg": 122.57339,
"epsHigh": 127.99129,
"epsLow": 117.89443,
"numAnalystsRevenue": 4,
"numAnalystsEps": 1
},
{
"symbol": "TAK",
"date": "2028-03-31",
"revenueLow": 4779870970643,
"revenueHigh": 4906313780866,
"revenueAvg": 4843092375755,
"ebitdaLow": 1206260486915,
"ebitdaHigh": 1267749700959,
"ebitdaAvg": 1238341823022,
"ebitLow": 546785559948,
"ebitHigh": 608274773992,
"ebitAvg": 578866896055,
"netIncomeLow": 296354384458,
"netIncomeHigh": 345041161994,
"netIncomeAvg": 321756187008,
"sgaExpenseLow": 1170970145592,
"sgaExpenseHigh": 1201946035277,
"sgaExpenseAvg": 1186458090434,
"epsAvg": 100.37422,
"epsHigh": 107.63814,
"epsLow": 92.44994,
"numAnalystsRevenue": 9,
"numAnalystsEps": 2
}
],
"price_target": {
"status": "not_found",
"endpoint": "price-target-consensus",
"provided": "symbol=\"TAK\"",
"message": "No data returned for price-target-consensus with symbol=\"TAK\". The identifier may not exist, or may have no data for this endpoint. Use the 'search' tool to verify the symbol/cik/name."
},
"ratings": {
"symbol": "TAK",
"rating": "B",
"overallScore": 3,
"discountedCashFlowScore": 4,
"returnOnEquityScore": 3,
"returnOnAssetsScore": 3,
"debtToEquityScore": 2,
"priceToEarningsScore": 1,
"priceToBookScore": 4
},
"grades": []
}
Data:
[
{
"title": "Are Investors Undervaluing Takeda Pharmaceutical Co. (TAK) Right Now?",
"url": "https://www.zacks.com/stock/news/2983657/are-investors-undervaluing-takeda-pharmaceutical-co-tak-right-now?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_2-2983657",
"source": "Zacks Investment Research",
"date": "2026-09-02 10:41:04",
"summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
"image": "https://images.financialmodelingprep.com/news/are-investors-undervaluing-takeda-pharmaceutical-co-tak-right-now-20260902.jpg"
},
{
"title": "Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?",
"url": "https://finance.yahoo.com/healthcare/articles/novavax-jumps-6-matrix-m-171213256.html",
"source": "Yahoo! Finance",
"date": "2026-09-01T17:12:13Z",
"summary": "Retail traders are treating Novavax as a cancer-vaccine play today, but the price action shows a single-name bid rather than a sector move. Novavax (NASDAQ:NVAX) stock is up 6% to $9.90 in midday trading. Shares of NVAX were up 39% year to date through Monday's close, and today's",
"image": "https://s.yimg.com/lo/mysterio/api/bfa9efb78db0de72d035a6a5a991919ed467bc48f6f8ffd956cc939852748121/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2F24_7_wall_st__718%2F6a00ce4836f0899d2894d4f37eefc3cd.jpg"
},
{
"title": "If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now",
"url": "https://www.zacks.com/stock/news/2982971/if-you-invested-1000-in-halozyme-therapeutics-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-ZC-FT-fundamental_analysis|investing_$1000-2982971",
"source": "Zacks Investment Research",
"date": "2026-09-01T12:30:01Z",
"summary": "A $1,000 investment in Halozyme Therapeutics made in September 2016 would be worth $10,866.33 as of September 1, 2026, representing a 986.63% gain. The biopharmaceutical company's success is driven by its ENHANZE drug delivery technology licensed to major pharma partners like Roc",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default60.jpg"
},
{
"title": "Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities",
"url": "https://www.businesswire.com/news/home/20260901015612/en/Weave-Bio-Announces-Collaboration-with-Takeda-to-Deploy-AI-Native-Regulatory-Automation-Across-Key-Drug-Development-Activities/",
"source": "Business Wire",
"date": "2026-09-01 09:00:00",
"summary": "SAN FRANCISCO--(BUSINESS WIRE)-- #AI--Weave Bio, the leader in AI-native regulatory automation for drug development, today announced a collaboration with Takeda to deploy the Weave platform across 14 active programs in multiple global markets. The collaboration brings together We",
"image": "https://images.financialmodelingprep.com/news/weave-bio-announces-collaboration-with-takeda-to-deploy-ainative-20260901.jpg"
},
{
"title": "Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers",
"url": "https://www.cnbc.com/2026/08/31/trump-drug-pricing-deals.html",
"source": "CNBC",
"date": "2026-08-31 13:20:45",
"summary": "Nearly a dozen drugmakers are reportedly slated to voluntarily sell their medications at lower prices under deals expected to be announced by President Donald Trump on Monday. The string of deals builds on the Trump administration's push to link the nation's drug prices to cheape",
"image": "https://images.financialmodelingprep.com/news/trump-reportedly-plans-to-announce-new-drug-pricing-deals-20260831.jpg"
},
{
"title": "FDA approves Takeda's Mimrylo for polycythemia vera treatment By Investing.com",
"url": "https://www.investing.com/news/company-news/fda-approves-takedas-mimrylo-for-polycythemia-vera-treatment-93CH-4881863",
"source": "Investing.com",
"date": "2026-08-28T22:44:31Z",
"summary": "OSAKA, Japan & CAMBRIDGE, Mass. - Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) announced Monday that the U.S. Food and Drug Administration has approved Mimrylo (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera, according to a press rel",
"image": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png"
},
{
"title": "Takeda Receives U.S. FDA Approval of MIMRYLO\u2122 (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera",
"url": "https://www.businesswire.com/news/home/20260824773270/en/Takeda-Receives-U.S.-FDA-Approval-of-MIMRYLO%E2%84%A2-rusfertide-Marking-a-Potential-Shift-in-the-Treatment-Paradigm-for-Polycythemia-Vera/",
"source": "Business Wire",
"date": "2026-08-28 18:40:00",
"summary": "OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO\u2122 (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood ",
"image": "https://images.financialmodelingprep.com/news/takeda-receives-us-fda-approval-of-mimrylo-rusfertide-marking-20260828.jpg"
},
{
"title": "US FDA approves Takeda, Protagonist's drug for rare blood cancer",
"url": "https://www.reuters.com/legal/litigation/us-fda-approves-takeda-protagonists-drug-rare-blood-cancer-2026-08-28/",
"source": "Reuters",
"date": "2026-08-28 17:39:51",
"summary": "The U.S. \u200bFood and \u200cDrug Administration \u200bhas approved a \u200bfirst-of-its-kind drug from \u2060Takeda \u200bPharmaceutical and \u200bProtagonist Therapeutics to treat \u200ba \u200brare blood cancer, the \u200chealth \u2060regulator said on \u200bFriday.",
"image": "https://images.financialmodelingprep.com/news/us-fda-approves-takeda-protagonists-drug-for-rare-blood-20260828.jpg"
},
{
"title": "Fabry Disease Treatment Market 2026-2031 - Growth Driven by Increasing Adoption of Enzyme Replacement Therapy",
"url": "https://www.globenewswire.com/news-release/2026/08/25/3350234/28124/en/fabry-disease-treatment-market-2026-2031-growth-driven-by-increasing-adoption-of-enzyme-replacement-therapy.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-25T08:04:39Z",
"summary": "The global Fabry disease treatment market is projected to grow from USD 2.63 billion in 2025 to USD 4.09 billion by 2031, with a CAGR of 7.63%. Growth is driven by expanded screening identifying more patients, advances in gene and mRNA therapies, and sustained enzyme replacement ",
"image": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7"
},
{
"title": "ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1",
"url": "https://www.businesswire.com/news/home/20260818063761/en/ORZEYFUL-oveporexton-Approved-in-Japan-as-the-First-and-Only-Medicine-to-Treat-the-Underlying-Cause-of-Narcolepsy-Type-1/",
"source": "Business Wire",
"date": "2026-08-24 02:36:00",
"summary": "OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. O",
"image": "https://images.financialmodelingprep.com/news/orzeyful-oveporexton-approved-in-japan-as-the-first-and-20260824.jpg"
},
{
"title": "Wall Street Analysts Think Takeda Pharmaceutical Co. (TAK) Could Surge 26.41%: Read This Before Placing a Bet",
"url": "https://www.zacks.com/stock/news/2976289/wall-street-analysts-think-takeda-pharmaceutical-co-tak-could-surge-26-41-read-this-before-placing-a-bet?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|consensus_price_target-2976289",
"source": "Zacks Investment Research",
"date": "2026-08-18 10:56:07",
"summary": "The consensus price target hints at a 26.4% upside potential for Takeda Pharmaceutical Co. (TAK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in t",
"image": "https://images.financialmodelingprep.com/news/wall-street-analysts-think-takeda-pharmaceutical-co-tak-could-20260818.jpg"
},
{
"title": "Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?",
"url": "https://www.zacks.com/stock/news/2975610/should-value-investors-buy-takeda-pharmaceutical-co-tak-stock?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_2-2975610",
"source": "Zacks Investment Research",
"date": "2026-08-17 10:42:15",
"summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
"image": "https://images.financialmodelingprep.com/news/should-value-investors-buy-takeda-pharmaceutical-co-tak-stock-20260817.jpg"
},
{
"title": "Best Income Stocks to Buy for August 17th",
"url": "https://www.zacks.com/commentary/2975555/best-income-stocks-to-buy-for-august-17th?cid=CS-STOCKNEWSAPI-FT-zacks_1_rank_additions|income_additions-2975555",
"source": "Zacks Investment Research",
"date": "2026-08-17 09:30:52",
"summary": "SBLK, TAK and STBA made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 17, 2026.",
"image": "https://images.financialmodelingprep.com/news/best-income-stocks-to-buy-for-august-17th-20260817.jpg"
},
{
"title": "New Strong Buy Stocks for August 17th",
"url": "https://www.zacks.com/commentary/2974382/new-strong-buy-stocks-for-august-17th?cid=CS-STOCKNEWSAPI-FT-zacks_1_rank_additions-2974382",
"source": "Zacks Investment Research",
"date": "2026-08-17 06:56:06",
"summary": "TAK, VLO, PFX, SBLK and RELY have been added to the Zacks Rank #1 (Strong Buy) List on August 17, 2026.",
"image": "https://images.financialmodelingprep.com/news/new-strong-buy-stocks-for-august-17th-20260817.jpg"
},
{
"title": "Can Keros Therapeutics (KROS)'s $20M Takeda Pharmaceutical Company Limited (TAK) Milestone Unlock a Billion-Dollar Opportunity?",
"url": "https://finance.yahoo.com/healthcare/articles/keros-therapeutics-kros-20m-takeda-233712991.html",
"source": "Yahoo! Finance",
"date": "2026-08-14T23:37:12Z",
"summary": "On July 30, Keros Therapeutics, Inc. (NASDAQ:KROS) triggered a $20 million development milestone payment from its global partner Takeda Pharmaceutical Company Limited (NYSE:TAK). The payout followed the first patient dosed in the Phase 3 ELRiSE MDS clinical trial, evaluating elri",
"image": "https://s.yimg.com/lo/mysterio/api/58D3C3DFEA401690C97A31B9D895FF213DAAB39CA6C8455B36E5C1C1044F4A9A/subgraphmysterio/resizefill_w1200_h673;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Finsidermonkey.com%2F59fe7bc4cb7379b8caecd6f09fabc66e.jpg"
},
{
"title": "Artizent, Insurity team up on insurer modernisation work",
"url": "https://finance.yahoo.com/technology/articles/artizent-insurity-team-insurer-modernisation-121304576.html",
"source": "Yahoo! Finance",
"date": "2026-08-13T12:13:04Z",
"summary": "Artizent has formed a strategic partnership with Insurity to support insurers pursuing modernisation programmes and launching new capabilities more quickly.\n\nInsurity provides cloud-based software for insurance carriers, brokers and managing general agents. Under the partnership,",
"image": "https://s.yimg.com/lo/mysterio/api/2E05B49D0C2AB6CDBA3CB4C7DF87A86CED886CE38B22A5A493D9FAE855EA5301/subgraphmysterio/resizefill_w1200_h675;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Flife_insurance_international_186%2Fbd1715cc2eaa617286ec2e5060483e09.jpg"
},
{
"title": "A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?",
"url": "https://finance.yahoo.com/healthcare/articles/profitable-rare-disease-prize-might-132039632.html",
"source": "Yahoo! Finance",
"date": "2026-08-11T13:20:39Z",
"summary": "* BioCryst hit its first full year of profitability in 2025, with Q2 2026 revenue up 34% to $218 million, fueling acquisition speculation.\n\n* Takeda (TAK) tops the buyer rankings as navenibart directly threatens its Takhzyro franchise; AstraZeneca (AZN) ranks second through its A",
"image": "https://s.yimg.com/lo/mysterio/api/828B4D3DC5287BEF8B29DEE026E7D6489C3C1F610789FC9DBF624B2C1F5DA16D/subgraphmysterio/resizefill_w1200_h670;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2F24_7_wall_st__718%2F64e7b675af8d86d37822f376fa2d28cb"
},
{
"title": "Crypto investor found dead outside his apartment",
"url": "https://finance.yahoo.com/markets/crypto/articles/crypto-investor-found-dead-outside-212830886.html",
"source": "Yahoo! Finance",
"date": "2026-08-10T21:28:30Z",
"summary": "Cryptocurrency investor Harry Chun Tak Yeh was found dead in Paraguay after falling from his luxury 30th floor apartment in the Trinidad district of Asunci\u00f3n last week, a local media outlet reported on Aug. 9.\n\nYeh entered Bitcoin (BTC) investment as early as 2013 and founded the",
"image": "https://s.yimg.com/lo/mysterio/api/91AF25A52A1039ECC34E0F7A1E133D5F1935458F7DB1026630EA27631A09766A/subgraphmysterio/resizefill_w1200_h800;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fthestreet_881%2Fe52e4afc1d86adc0ba483d451ee3f2fd"
},
{
"title": "Earnings call transcript: G R Infraprojects posts strong Q1 2027 growth, stock slips By Investing.com",
"url": "https://www.investing.com/news/transcripts/earnings-call-transcript-g-r-infraprojects-posts-strong-q1-2027-growth-stock-slips-93CH-4845436",
"source": "Investing.com",
"date": "2026-08-07T09:00:03Z",
"summary": "G R Infraprojects Ltd. said first-quarter revenue rose sharply and its order book remained strong, but margins came under pressure from higher material costs and the stock eased 0.76% to $883.20 after the call. The company reported standalone revenue growth of 32.71% year over ye",
"image": "https://i-invdn-com.investing.com/news/moved_LYNXMPEM3T1AG_1200_L.jpg"
},
{
"title": "Takeda's Pipeline Looks Encouraging, But Generic Erosion Is A Near-Term Concern",
"url": "https://seekingalpha.com/article/4932968-takedas-pipeline-looks-encouraging-but-generic-erosion-is-a-near-term-concern",
"source": "Seeking Alpha",
"date": "2026-08-07 08:18:10",
"summary": "Takeda Pharmaceuticals (TAK) remains a hold, with shares near 52-week highs and uncertainty about a major successor to Entyvio. TAK's Q1 showed 10% revenue growth, but bottom-line weakness from higher taxes and lower operating cash flow due to mounting receivables. Orzeyful's FDA",
"image": "https://images.financialmodelingprep.com/news/takedas-pipeline-looks-encouraging-but-generic-erosion-is-a-20260807.jpg"
},
{
"title": "Hong Kong's Skyline Revamp Points to Life Beyond Just Finance",
"url": "https://www.bloomberg.com/news/newsletters/2026-08-06/hong-kong-s-skyline-revamp-points-to-life-beyond-just-finance",
"source": "Bloomberg Business",
"date": "2026-08-06T04:29:08Z",
"summary": "In this week's Hong Kong Edition, Venus Feng and Eunice Xu take a look at the new architectural landmarks springing up across the city, Pei Li and Pui Gwen Yeung talk football fanatics with promoter TEG, and David Ingles asks whether the stock exchange itself is the best baromete",
"image": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/imUkYNCmtAAQ/v15/1200x800.jpg"
},
{
"title": "Takeda Achieves Major Milestone With Holistic Narcolepsy Drug Approval",
"url": "https://www.benzinga.com/news/fda/26/08/61003390/takeda-achieves-major-milestone-with-holistic-narcolepsy-drug-approval",
"source": "Benzinga",
"date": "2026-08-06 11:16:02",
"summary": "On Wednesday, the U.S. Food and Drug Administration (FDA) approved Takeda Pharmaceutical Co. Ltd.\u2018s (NYSE:TAK) Orzeyful (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.",
"image": "https://images.financialmodelingprep.com/news/takeda-achieves-major-milestone-with-holistic-narcolepsy-drug-approval-20260806.jpg"
},
{
"title": "U.S. FDA Approves Takeda's ORZEYFUL\u2122 (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1",
"url": "https://www.businesswire.com/news/home/20260805760759/en/U.S.-FDA-Approves-Takeda%E2%80%99s-ORZEYFUL%E2%84%A2-oveporexton-the-First-and-Only-Medicine-to-Treat-the-Underlying-Cause-of-Narcolepsy-Type-1/",
"source": "Business Wire",
"date": "2026-08-05 18:10:00",
"summary": "OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL\u2122 (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataple",
"image": "https://images.financialmodelingprep.com/news/us-fda-approves-takedas-orzeyful-oveporexton-the-first-and-20260805.jpg"
},
{
"title": "US FDA approves Takeda's sleep disorder pill",
"url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-takedas-sleep-disorder-pill-2026-08-05/",
"source": "Reuters",
"date": "2026-08-05 17:47:35",
"summary": "The FDA has approved Takeda Pharmaceuticals' oral drug for narcolepsy, the U.S. \u200bhealth regulator said on Wednesday, backing \u200cthe first treatment that targets all the symptoms of the rare sleep disorder.",
"image": "https://images.financialmodelingprep.com/news/us-fda-approves-takedas-sleep-disorder-pill-20260805.jpg"
},
{
"title": "Takeda Pharmaceutical Company Limited (TAK) Q1 2027 Earnings Call Transcript",
"url": "https://seekingalpha.com/article/4927638-takeda-pharmaceutical-company-limited-tak-q1-2027-earnings-call-transcript",
"source": "Seeking Alpha",
"date": "2026-07-30 12:13:52",
"summary": "Takeda Pharmaceutical Company Limited (TAK) Q1 2027 Earnings Call Transcript",
"image": "https://images.financialmodelingprep.com/news/takeda-pharmaceutical-company-limited-tak-q1-2027-earnings-call-transcript-20260730.jpg"
}
]
Data:
[
{
"symbol": "TAK",
"date": "2026-10-29",
"epsActual": null,
"epsEstimated": 0.1457,
"revenueActual": null,
"revenueEstimated": 7263491000,
"lastUpdated": "2026-09-03"
},
{
"symbol": "TAK",
"date": "2026-07-30",
"epsActual": 0.225,
"epsEstimated": 0.1689,
"revenueActual": 7661485000,
"revenueEstimated": 7133689000,
"lastUpdated": "2026-09-03"
},
{
"symbol": "TAK",
"date": "2026-05-13",
"epsActual": -0.04919,
"epsEstimated": 0.21,
"revenueActual": 6921123000,
"revenueEstimated": 7135730000,
"lastUpdated": "2026-08-17"
},
{
"symbol": "TAK",
"date": "2026-01-29",
"epsActual": 0.2131,
"epsEstimated": 0.55,
"revenueActual": 7725256000,
"revenueEstimated": 7538620000,
"lastUpdated": "2026-08-17"
},
{
"symbol": "TAK",
"date": "2025-10-30",
"epsActual": -0.02493,
"epsEstimated": 0.44,
"revenueActual": 7223368000,
"revenueEstimated": 7793711000,
"lastUpdated": "2026-08-17"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "TAK",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "TAK",
"periods": [
{
"file_period": "202604b",
"settlement_date": "20260421",
"quantity_fails": 2639,
"price": 17.55
},
{
"file_period": "202606a",
"settlement_date": "20260608",
"quantity_fails": 488,
"price": 15.6
},
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 1,
"price": 15.98
},
{
"file_period": "202607a",
"settlement_date": "20260713",
"quantity_fails": 134,
"price": 16.56
},
{
"file_period": "202607b",
"settlement_date": "20260729",
"quantity_fails": 11086,
"price": 17.52
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "TAK",
"filingDate": "2026-08-21",
"transactionDate": "2026-08-19",
"reportingCik": "0001977689",
"companyCik": "0001395064",
"transactionType": "S-Sale",
"securitiesOwned": 261656,
"reportingName": "Plump Andrew Stewart",
"typeOfOwner": "director, officer: President, R&D",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 19651,
"price": 18.49,
"securityName": "American Depositary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1395064/000149315226039693/0001493152-26-039693-index.htm"
},
{
"symbol": "TAK",
"filingDate": "2026-08-19",
"transactionDate": "2026-08-18",
"reportingCik": "0002123546",
"companyCik": "0001395064",
"transactionType": "S-Sale",
"securitiesOwned": 40049,
"reportingName": "Greenway Nicola Deidre Petal",
"typeOfOwner": "officer: Chief Human Resources Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 12980,
"price": 18.1139,
"securityName": "American Depositary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1395064/000149315226039214/0001493152-26-039214-index.htm"
},
{
"symbol": "TAK",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-10",
"reportingCik": "0002121389",
"companyCik": "0001395064",
"transactionType": "S-Sale",
"securitiesOwned": 116177,
"reportingName": "Farajallah Awny Samaan Botros",
"typeOfOwner": "officer: Chief Medical Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 14006,
"price": 17.1,
"securityName": "American Depositary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1395064/000149315226037515/0001493152-26-037515-index.htm"
},
{
"symbol": "TAK",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-10",
"reportingCik": "0002121395",
"companyCik": "0001395064",
"transactionType": "S-Sale",
"securitiesOwned": 102588,
"reportingName": "Ibrahim Ramy Riad Ahmed",
"typeOfOwner": "officer: President, PDT BU",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 7277,
"price": 17.1,
"securityName": "American Depositary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1395064/000149315226037514/0001493152-26-037514-index.htm"
},
{
"symbol": "TAK",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-10",
"reportingCik": "0002111489",
"companyCik": "0001395064",
"transactionType": "S-Sale",
"securitiesOwned": 182507,
"reportingName": "Pacheco Rhonda Janice",
"typeOfOwner": "officer: President, U.S. Business Unit",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 16901,
"price": 17.1,
"securityName": "American Depositary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1395064/000149315226037513/0001493152-26-037513-index.htm"
},
{
"symbol": "TAK",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-10",
"reportingCik": "0001977746",
"companyCik": "0001395064",
"transactionType": "S-Sale",
"securitiesOwned": 226057,
"reportingName": "Duprey Lauren Rusckowski",
"typeOfOwner": "officer: Chief Transformation Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 47586,
"price": 17.1,
"securityName": "American Depositary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1395064/000149315226037509/0001493152-26-037509-index.htm"
},
{
"symbol": "TAK",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-10",
"reportingCik": "0001977689",
"companyCik": "0001395064",
"transactionType": "S-Sale",
"securitiesOwned": 766569,
"reportingName": "Plump Andrew Stewart",
"typeOfOwner": "director, officer: President, R&D",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 165393,
"price": 17.1,
"securityName": "American Depositary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1395064/000149315226037507/0001493152-26-037507-index.htm"
},
{
"symbol": "TAK",
"filingDate": "2026-08-12",
"transactionDate": "2026-08-10",
"reportingCik": "0001977817",
"companyCik": "0001395064",
"transactionType": "S-Sale",
"securitiesOwned": 176977,
"reportingName": "Pignagnoli Agosti Marcello",
"typeOfOwner": "officer: Head, Strat. & Port. Dev",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 22957,
"price": 17.1,
"securityName": "American Depositary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/1395064/000149315226037505/0001493152-26-037505-index.htm"
}
],
"congress": [
"status",
"endpoint",
"provided",
"message",
{
"symbol": "TAK",
"senateID": "",
"disclosureDate": "2023-09-05",
"transactionDate": "2023-08-29",
"firstName": "Virginia",
"lastName": "Foxx",
"office": "Virginia Foxx",
"district": "NC05",
"owner": "Joint",
"assetDescription": "Takeda Pharmaceutical Co Ltd",
"assetType": "Stock",
"type": "Sale",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023613.pdf"
},
{
"symbol": "TAK",
"senateID": "D000625",
"disclosureDate": "2023-08-13",
"transactionDate": "2023-07-10",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "Takeda Pharmaceutical Co Ltd",
"assetType": "Stock",
"type": "Sale",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023404.pdf"
},
{
"symbol": "TAK",
"senateID": "K000389",
"disclosureDate": "2023-04-07",
"transactionDate": "2023-03-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Takeda Pharmaceutical Co Ltd",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219444.pdf"
},
{
"symbol": "TAK",
"senateID": "D000625",
"disclosureDate": "2023-03-20",
"transactionDate": "2023-02-27",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "Takeda Pharmaceutical Co Ltd",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022480.pdf"
},
{
"symbol": "TAK",
"senateID": "K000389",
"disclosureDate": "2023-03-08",
"transactionDate": "2023-02-10",
"firstName": "Ro",
"lastName": "Khanna",
"office": "Ro Khanna",
"district": "CA17",
"owner": "Spouse",
"assetDescription": "Takeda Pharmaceutical Co Ltd",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/8219417.pdf"
},
{
"symbol": "TAK",
"senateID": "",
"disclosureDate": "2023-03-03",
"transactionDate": "2023-02-16",
"firstName": "Virginia",
"lastName": "Foxx",
"office": "Virginia Foxx",
"district": "NC05",
"owner": "Joint",
"assetDescription": "Takeda Pharmaceutical Company Limited American Depositary Shares",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022504.pdf"
},
{
"symbol": "TAK",
"senateID": "",
"disclosureDate": "2022-12-06",
"transactionDate": "2022-11-01",
"firstName": "Virginia",
"lastName": "Foxx",
"office": "Virginia Foxx",
"district": "NC05",
"owner": "Joint",
"assetDescription": "Takeda Pharmaceutical Company Common Units Limited ADR Shares",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20022068.pdf"
}
],
"dark_pool": [
{
"ticker": "TAK",
"executed_at": "2026-09-03T14:08:10.386000Z",
"size": 2009.0,
"price": 18.6501,
"premium": 37468.050899999995,
"volume": 2009.0,
"trade_code": " "
},
{
"ticker": "TAK",
"executed_at": "2026-09-03T14:07:11.612000Z",
"size": 900.0,
"price": 18.64,
"premium": 16776.0,
"volume": 900.0,
"trade_code": " "
},
{
"ticker": "TAK",
"executed_at": "2026-09-03T14:08:59.311000Z",
"size": 641.0,
"price": 18.6391,
"premium": 11947.6631,
"volume": 641.0,
"trade_code": " "
},
{
"ticker": "TAK",
"executed_at": "2026-09-03T14:05:21.174000Z",
"size": 590.0,
"price": 18.64,
"premium": 10997.6,
"volume": 590.0,
"trade_code": " "
},
{
"ticker": "TAK",
"executed_at": "2026-09-03T14:07:20.831000Z",
"size": 571.0,
"price": 18.655,
"premium": 10652.005000000001,
"volume": 571.0,
"trade_code": " "
},
{
"ticker": "TAK",
"executed_at": "2026-09-03T14:07:09.265000Z",
"size": 571.0,
"price": 18.6399,
"premium": 10643.3829,
"volume": 571.0,
"trade_code": " "
},
{
"ticker": "TAK",
"executed_at": "2026-09-03T14:02:27.075000Z",
"size": 405.0,
"price": 18.615,
"premium": 7539.075,
"volume": 405.0,
"trade_code": " "
},
{
"ticker": "TAK",
"executed_at": "2026-09-03T14:00:59.423000Z",
"size": 303.0,
"price": 18.615,
"premium": 5640.344999999999,
"volume": 303.0,
"trade_code": " "
}
],
"ats": {
"symbol": "TAK",
"date": "20260902",
"ats_volume": 0,
"total_volume": 727912,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260902",
"ats_ratio": 0.0
},
{
"date": "20260901",
"ats_ratio": 0.0
},
{
"date": "20260831",
"ats_ratio": 0.0
},
{
"date": "20260828",
"ats_ratio": 0.0
},
{
"date": "20260827",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "TAK",
"days": [
{
"date": "2026-09-03",
"close": 18.6391,
"vwap": 18.71,
"volume": 741553,
"vwap_discount_pct": 0.38
},
{
"date": "2026-09-02",
"close": 18.43,
"vwap": 18.41,
"volume": 1721820,
"vwap_discount_pct": -0.11
},
{
"date": "2026-09-01",
"close": 18.23,
"vwap": 18.25,
"volume": 1899444,
"vwap_discount_pct": 0.12
},
{
"date": "2026-08-31",
"close": 17.98,
"vwap": 18.0,
"volume": 1779519,
"vwap_discount_pct": 0.1
},
{
"date": "2026-08-28",
"close": 18.03,
"vwap": 18.01,
"volume": 1809972,
"vwap_discount_pct": -0.09
}
],
"avg_vwap_discount_pct": 0.08,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "TAK",
"net_call_premium": "-860.00",
"net_put_premium": "0",
"call_premium": "980.00",
"put_premium": "0",
"bullish_premium": "60.00",
"bearish_premium": "920.00",
"put_call_ratio": "0.00000000000000000000",
"iv_rank": "41.9913",
"implied_move_perc": "0.063000",
"gex_ratio": "0.06293523317997140085",
"gex_net_change": "27057.5121",
"gex_call": "68697.6433",
"gex_put": "-4323.5022",
"gex_net": 64374.1411,
"gex_call_delta": "164025.0795",
"gex_put_delta": "-8063.9793",
"gex_date": "2026-09-03"
},
"hot_chains": [
{
"underlying_symbol": "TAK",
"expires": "2026-09-18",
"open_interest": 47,
"option_type": "call",
"delta": 0.849837089535204,
"ask_volume": 0,
"last_price": "1.30",
"implied_volatility": "0.465717322498615",
"gamma": 0.2010762000780914,
"avg_price": "1.3000000000000000000000000000",
"bid_volume": 6,
"nbbo_ask": "1.55",
"strike": "17.5",
"option_symbol": "TAK260918C00017500",
"total_premium": "780.00",
"iv": 0.304770083565022,
"volume": 6,
"nbbo_bid": "1.30"
},
{
"underlying_symbol": "TAK",
"expires": "2026-10-16",
"open_interest": 1927,
"option_type": "call",
"delta": 0.1451845102012954,
"ask_volume": 4,
"last_price": "0.15",
"implied_volatility": "0.1959835240450898",
"gamma": 0.1880665195210637,
"avg_price": "0.1500",
"bid_volume": 0,
"nbbo_ask": "0.20",
"strike": "20",
"option_symbol": "TAK261016C00020000",
"total_premium": "60.00",
"iv": 0.1891525492741565,
"volume": 4,
"nbbo_bid": "0.05"
},
{
"underlying_symbol": "TAK",
"expires": "2026-10-16",
"open_interest": 673,
"option_type": "call",
"delta": 0.849836959033808,
"ask_volume": 0,
"last_price": "1.40",
"implied_volatility": "0.1738657332963062",
"gamma": 0.2010762010293898,
"avg_price": "1.40",
"bid_volume": 1,
"nbbo_ask": "1.45",
"strike": "17.5",
"option_symbol": "TAK261016C00017500",
"total_premium": "140.00",
"iv": 0.1809548506924804,
"volume": 1,
"nbbo_bid": "1.30"
},
{
"underlying_symbol": "TAK",
"expires": "2027-01-15",
"open_interest": 503,
"option_type": "call",
"delta": 0.318924175310638,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.145007920704001,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "20",
"option_symbol": "TAK270115C00020000",
"total_premium": "0",
"iv": 0.2179327141396896,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "TAK",
"expires": "2027-01-15",
"open_interest": 276,
"option_type": "call",
"delta": 0.738037986713285,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.1630477771122112,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "17.5",
"option_symbol": "TAK270115C00017500",
"total_premium": "0",
"iv": 0.1767319407627179,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "TAK",
"expires": "2027-01-15",
"open_interest": 180,
"option_type": "put",
"delta": -0.302196646285218,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.1341536314414004,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "17.5",
"option_symbol": "TAK270115P00017500",
"total_premium": "0",
"iv": 0.230111150490924,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "TAK",
"expires": "2027-01-15",
"open_interest": 176,
"option_type": "call",
"delta": 0.875904714367149,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.053350250612528,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "15",
"option_symbol": "TAK270115C00015000",
"total_premium": "0",
"iv": 0.339729447591366,
"volume": 0,
"nbbo_bid": null
},
{
"underlying_symbol": "TAK",
"expires": "2026-10-16",
"open_interest": 132,
"option_type": "call",
"delta": 0.0759135904814393,
"ask_volume": 0,
"last_price": null,
"implied_volatility": null,
"gamma": 0.0607906128315817,
"avg_price": null,
"bid_volume": 0,
"nbbo_ask": null,
"strike": "22.5",
"option_symbol": "TAK261016C00022500",
"total_premium": "0",
"iv": 0.366489812820729,
"volume": 0,
"nbbo_bid": null
}
],
"gamma_profile": {
"ticker": "TAK",
"spot": 18.6391,
"date": "2026-09-03",
"flip_point": 12.72,
"net_gex": 64374.14,
"call_walls": [
{
"strike": 20.0,
"gex": 48597.05
},
{
"strike": 17.5,
"gex": 17503.56
},
{
"strike": 15.0,
"gex": 1428.4
}
],
"put_walls": [
{
"strike": 17.5,
"gex": -3722.07
},
{
"strike": 15.0,
"gex": -454.47
},
{
"strike": 12.5,
"gex": -112.57
}
],
"by_strike": [
{
"strike": 2.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 5.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 7.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 10.0,
"call_gex": 0.61,
"put_gex": 0.0,
"net_gex": 0.61
},
{
"strike": 12.5,
"call_gex": 27.52,
"put_gex": -112.57,
"net_gex": -85.05
},
{
"strike": 15.0,
"call_gex": 1428.4,
"put_gex": -454.47,
"net_gex": 973.93
},
{
"strike": 17.5,
"call_gex": 17503.56,
"put_gex": -3722.07,
"net_gex": 13781.49
},
{
"strike": 20.0,
"call_gex": 48597.05,
"put_gex": -34.39,
"net_gex": 48562.66
},
{
"strike": 22.5,
"call_gex": 1112.17,
"put_gex": 0.0,
"net_gex": 1112.17
},
{
"strike": 25.0,
"call_gex": 28.3,
"put_gex": 0.0,
"net_gex": 28.3
},
{
"strike": 30.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 35.0,
"call_gex": 0.03,
"put_gex": 0.0,
"net_gex": 0.03
}
]
},
"oi_changes": {
"net_call_oi_change": 1331,
"net_put_oi_change": 0,
"top": [
{
"strike": "20",
"oi_change": 1332,
"type": "call"
},
{
"strike": "17.5",
"oi_change": -2,
"type": "call"
},
{
"strike": "20",
"oi_change": 1,
"type": "call"
},
{
"strike": "17.5",
"oi_change": 0,
"type": "call"
},
{
"strike": "17.5",
"oi_change": 0,
"type": "put"
}
]
},
"opds": {
"opds": -5.3,
"D": -26.5,
"P": 59.0,
"O": 6.0,
"C": 20.0,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.85,
"ranked": true,
"components": {
"M": 79.5,
"T": 65.6,
"RS": 74.0,
"V": 0.0,
"F": -87.8,
"OI": 100.0,
"S": -4.4,
"IV": 87.9,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": null,
"FlowAgreement": 50.0,
"StrikeBreadth": null
},
"drivers": [
"+ open-interest change +100",
"+ IV behaviour +88",
"- aggressive flow -88",
"+ momentum +79",
"+ relative strength +74"
]
}
}
Data:
{
"vix": 14.92,
"sp500": 7686.14,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.41,
"hy_spread": 2.6,
"treasury": {
"date": "2026-09-01",
"month1": 3.85,
"month2": 3.89,
"month3": 3.92,
"month6": 4,
"year1": 4.18,
"year2": 4.39,
"year3": 4.46,
"year5": 4.55,
"year7": 4.66,
"year10": 4.79,
"year20": 5.27,
"year30": 5.27
},
"events": [
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.1%",
"actual": null,
"minutes_until": 1344
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "55K",
"previous": "-23K",
"actual": null,
"minutes_until": 1344
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-09-04",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 1344
}
]
}
Data:
{
"days": 105,
"patterns": [
{
"name": "VWAP Touch",
"count": 105,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 105,
"pct": 100
},
{
"name": "PDH/PDL Touch",
"count": 96,
"pct": 91
},
{
"name": "ORB Breakout",
"count": 93,
"pct": 89
},
{
"name": "Woodie Pivot Touch",
"count": 87,
"pct": 83
},
{
"name": "Open Retracement",
"count": 69,
"pct": 66
},
{
"name": "Gap Fill",
"count": 46,
"pct": 44
},
{
"name": "Darvas Box",
"count": 42,
"pct": 40
},
{
"name": "High Vol Open",
"count": 25,
"pct": 24
},
{
"name": "Power Hour",
"count": 18,
"pct": 17
}
]
}